12:30 to 13:30
Seminar

Biotechnology and Big Pharma

Guy Eiferman
Biotechnology and society
12:30 to 13:30
    Amphithéâtre Marguerite de Navarre, Site Marcelin Berthelot
    Open to all, subject to availability
    -

    Documents and media

    Speaker(s)

    Guy Eiferman

    Vice-President and General Manager, Atherosclerosis and Cardiovascular, Merck & Co

    Events

    Lecture
    10:00 to 11:00
    Jean-Paul Clozel

    Setting up a biotech company. From innovative concept to first steps
    Lecture
    11:00 to 12:00
    Jean-Paul Clozel

    Setting up a biotech company. From first steps to IPO
    Lecture
    10:00 to 11:00
    Jean-Paul Clozel

    Drug discovery in biotechnology. Research or innovation ?
    Lecture
    11:00 to 12:00
    Jean-Paul Clozel

    Biotechnology drug discovery. From product to drug
    Lecture
    10:00 to 11:00
    Jean-Paul Clozel

    Biotechnology drug discovery. Biotech drug development
    Lecture
    11:00 to 12:00
    Jean-Paul Clozel

    Drug discovery in biotechnology. Biotechnology : What's the right business model?
    Lecture
    10:00 to 11:00
    Jean-Paul Clozel

    Drug discovery in biotechnology.…
    Lecture
    11:00 to 12:00
    Jean-Paul Clozel

    Drug discovery in biotechnology. Biotechnology in society : tomorrow's major challenges
    Seminar
    09:00 to 10:00
    Jean-Paul Clozel

    Opening
    Seminar
    09:30 to 10:30
    Denis Lucquin

    Founding a biotech company. The role of venture capital
    Seminar
    10:00 to 11:00
    André Mueller

    The finance function in the development of high-potential biotech companies
    Seminar
    11:00 to 12:00
    Jean-Christophe Galloux

    The importance of intellectual property in biotechnology
    Seminar
    11:30 to 12:30
    Martine Clozel

    Biotechnology and University. Biotechnology drug discovery : from idea to product
    Seminar
    12:00 to 13:00
    Joël Ménard

    Academic medicine and therapeutic research
    Seminar
    12:30 to 13:30
    Noel Renaudin

    Biotechnology in society. Biotechnology and drug costs
    Seminar
    12:30 to 13:30
    Guy Eiferman

    Biotechnology and Big Pharma

    Seminar
    13:00 to 14:00
    Antoine Flahaut

    Emerging infectious diseases
    Seminar
    13:30 to 14:30
    François Maisonrouge

    Biotechnology in the United States : reasons for success
    Seminar
    14:00 to 15:00
    Rafaël Benjumea

    Biotechnology in Spain : the example of the Botín Foundation

    See also

    Lecture related to the seminar: Biotechnology : from science to medicine
    Jean-Paul Clozel, chair Technological innovation Liliane Bettencourt
    Biotechnology and society